Literature DB >> 3427403

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

P A McCombe1, J D Pollard, J G McLeod.   

Abstract

Ninety-two patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have been studied in order to define better the clinical features, course and prognosis of the condition and to identify possible aetiological factors. Sural nerve biopsy was performed on 87 subjects. Electrophysiological studies were undertaken on all patients and demonstrated marked slowing of motor conduction and impairment of sensory conduction. The onset was usually gradual but there was a rapid rate of onset in 15 (16%) patients. Males were more commonly affected than females. Weakness and paraesthesiae were the most common symptoms but pain was frequently a feature. Age of onset ranged from 2 to 72 years. Sixty patients (65%) had a relapsing course and 32 patients (35%) a progressive or monophasic course; there was a significantly earlier age of onset in patients with relapsing disease. Thirty-two patients (35%) gave a history of preceding infection or some other possible antecedent precipitating event and there was a significantly higher titre for cytomegalovirus antibodies in the serum of patients with CIDP than in controls. The patients were followed up for an average time of approximately ten years. Most patients (73%) had made a good recovery and were independent, but 7 patients had either died or were completely immobilized as a result of their disease. The value of treatment with corticosteroid therapy, immunosuppressive agents and plasma exchange is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3427403     DOI: 10.1093/brain/110.6.1617

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  70 in total

Review 1.  Chronic inflammatory demyelinative polyneuropathy.

Authors:  Gérard Said
Journal:  J Neurol       Date:  2002-03       Impact factor: 4.849

Review 2.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  G Comi; L Roveri
Journal:  Ital J Neurol Sci       Date:  1998-10

3.  Chronic Inflammatory Demyelinating Polyneuropathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 4.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Chronic immune sensory polyradiculopathy with cranial and peripheral nerve involvement.

Authors:  S Anand Trip; Tabish Saifee; Will Honan; Hoskote Chandrashekar; Michael P Lunn; Tarek Yousry; Martin Koltzenburg; Mary M Reilly
Journal:  J Neurol       Date:  2011-11-29       Impact factor: 4.849

6.  Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases.

Authors:  S Kuwabara; S Misawa; M Mori; N Tamura; M Kubota; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 7.  Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard Ac Hughes; Man Mohan Mehndiratta; Yusuf A Rajabally
Journal:  Cochrane Database Syst Rev       Date:  2017-11-29

8.  Unmyelinated fibers in sural nerve biopsies of chronic inflammatory demyelinating polyneuropathy.

Authors:  E Gibbels; M Kentenich
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 9.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

10.  Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.

Authors:  S J Hodgkinson; J D Pollard; J G McLeod
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.